A couple of committee members asked about work product, and I want to just be clear that what we're talking about is de-identified data. It does not have any direct patient information on it, and the research that is done goes through ethics approval, very structured research. It is important not to just collect prescription utilization data but other health data as well to inform policy-making and that type of thing. It is certainly de-identified and it goes through very rigorous ethics boards.
On March 24th, 2015. See this statement in context.